John Crumpler - Net Worth and Insider Trading

John Crumpler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Crumpler owns 3 companies in total, including PhaseBio Pharmaceuticals Inc (PHASQ) , G1 Therapeutics Inc (GTHX) , and Clearside Biomedical Inc (CLSD) .

Click here to see the complete history of John Crumpler’s form 4 insider trades.

Insider Ownership Summary of John Crumpler

Ticker	Comapny	Transaction Date	Type of Owner
PHASQ	PhaseBio Pharmaceuticals Inc	2018-10-17	10 percent owner
GTHX	G1 Therapeutics Inc	2017-05-22	10 percent owner
CLSD	Clearside Biomedical Inc	2016-06-01	10 percent owner

John Crumpler Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Crumpler Ownership Network

Ownership Network List of John Crumpler

No Data

Ownership Network Relation of John Crumpler

John Crumpler Owned Company Details

What does PhaseBio Pharmaceuticals Inc do?

Who are the key executives at PhaseBio Pharmaceuticals Inc?

John Crumpler is the 10 percent owner of PhaseBio Pharmaceuticals Inc. Other key executives at PhaseBio Pharmaceuticals Inc include 10 percent owner New Enterprise Associates 13 Lp , VP & Human Resources Glen Burkhardt , and Chief Commercial Officer Jonathan Birchall .

PhaseBio Pharmaceuticals Inc (PHASQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhaseBio Pharmaceuticals Inc (PHASQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

PhaseBio Pharmaceuticals Inc Insider Transactions

No Available Data

What does G1 Therapeutics Inc do?

Who are the key executives at G1 Therapeutics Inc?

John Crumpler is the 10 percent owner of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Business Officer Mark Avagliano .

G1 Therapeutics Inc (GTHX) Insider Trades Summary

Over the past 18 months, John Crumpler made no insider transaction in G1 Therapeutics Inc (GTHX). Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,166 shares made by Rajesh Malik , a net sale of 92,308 shares made by Bailey John E. (jack) Jr. , and a net sale of 15,968 shares made by John V. Umstead .

In summary, during the past 3 months, insiders sold 0 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 295,121 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,121 shares.

G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.

G1 Therapeutics Inc Insider Transactions

No Available Data

What does Clearside Biomedical Inc do?

Who are the key executives at Clearside Biomedical Inc?

John Crumpler is the 10 percent owner of Clearside Biomedical Inc. Other key executives at Clearside Biomedical Inc include 10 percent owner Bradford T Whitmore , Chief Financial Officer Charles A. Deignan , and director & 10 percent owner Clay Thorp .

Clearside Biomedical Inc (CLSD) Insider Trades Summary

Over the past 18 months, John Crumpler made no insider transaction in Clearside Biomedical Inc (CLSD). Other recent insider transactions involving Clearside Biomedical Inc (CLSD) include a net purchase of 90,000 shares made by , a net purchase of 580,222 shares made by Bradford T Whitmore , and a net purchase of 100,000 shares made by Anthony S Gibney .

In summary, during the past 3 months, insiders sold 0 shares of Clearside Biomedical Inc (CLSD) in total and bought 36,500 shares, with a net purchase of 36,500 shares. During the past 18 months, 30,900 shares of Clearside Biomedical Inc (CLSD) were sold and 798,035 shares were bought by its insiders, resulting in a net purchase of 767,135 shares.

Clearside Biomedical Inc (CLSD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clearside Biomedical Inc Insider Transactions

No Available Data

John Crumpler Mailing Address

Above is the net worth, insider trading, and ownership report for John Crumpler. You might contact John Crumpler via mailing address: 280 S. Mangum Street, Suite 350, Durham Nc 27701.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.